Close Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Close Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000	Closed	-$2K	–	217
2022 Q3	$2K	Hold	2,000	–	–	﹤0.01%	178
2022 Q2	$4K	Hold	2,000	–	–	﹤0.01%	174
2022 Q1	$5K	Hold	2,000	–	–	﹤0.01%	195
2021 Q4	$5K	Hold	2,000	–	–	﹤0.01%	195
2021 Q3	$9K	Hold	2,000	–	–	﹤0.01%	189
2021 Q2	$12K	Hold	2,000	–	–	﹤0.01%	173
2021 Q1	$14K	Hold	2,000	–	–	﹤0.01%	176
2020 Q4	$10K	Hold	2,000	–	–	﹤0.01%	117
2020 Q3	$12K	Hold	2,000	–	–	﹤0.01%	119
2020 Q2	$13K	Hold	2,000	–	–	﹤0.01%	121
2020 Q1	$13K	Hold	2,000	–	–	﹤0.01%	126
2019 Q4	$21K	Hold	2,000	–	–	﹤0.01%	133
2019 Q3	$8K	Hold	2,000	–	–	﹤0.01%	156
2019 Q2	$30K	Sell	2,000 -375	-16%	-$6.78K	﹤0.01%	129
2019 Q1	$59K	Buy	2,375 +300	+14%	+$7.52K	0.01%	126
2018 Q4	$98K	Buy	2,075 +450	+28%	+$9.2K	0.01%	101
2018 Q3	$48K	Sell	1,625 -175	-10%	-$6.78K	﹤0.01%	137
2018 Q2	$90K	Hold	1,800	–	–	0.01%	112
2018 Q1	$90K	Hold	1,800	–	–	0.01%	115
2017 Q4	$122K	Sell	1,800 -75	-4%	-$5.24K	0.01%	101
2017 Q3	$155K	Hold	1,875	–	–	0.02%	93
2017 Q2	$176K	Sell	1,875 -1,125	-38%	-$68.8K	0.02%	88
2017 Q1	$191K	Buy	+3,000	New	+$182K	0.02%	88

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Close Asset Management's CLVS Position: Q4 2022 in Review

Close Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 2,000 shares — an estimated $2K sold.

Close Asset Management first reported a position in CLVS in Q1 2017 and held it in 23 quarters. The position peaked at $191K in Q1 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Close Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Close Asset Management sold 2,000 Clovis Oncology, Inc. shares in Q4 2022, an estimated $2K.
Close Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 23 quarters.
Close Asset Management's Clovis Oncology, Inc. position peaked at $191K in Q1 2017.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Close Asset Management's 13F filing for Q4 2022, filed 27 Jan 2023.